Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique. Issue 4 (April 2017)
- Record Type:
- Journal Article
- Title:
- Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique. Issue 4 (April 2017)
- Main Title:
- Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique
- Authors:
- Haidari, Leila A.
Brown, Shawn T.
Constenla, Dagna
Zenkov, Eli
Ferguson, Marie
de Broucker, Gatien
Ozawa, Sachiko
Clark, Samantha
Portnoy, Allison
Lee, Bruce Y. - Abstract:
- Abstract : Background: Research has shown that the distance to the nearest immunization location can ultimately prevent someone from getting immunized. With the introduction of human papillomavirus (HPV) vaccine throughout the world, a major question is whether the target populations can readily access immunization. Methods: In anticipation of HPV vaccine introduction in Mozambique, a country with a 2015 population of 25, 727, 911, our team developed Strategic Integrated Geo-temporal Mapping Application) to determine the potential economic impact of HPV immunization. We quantified how many people in the target population are reachable by the 1377 existing immunization locations, how many cannot access these locations, and the potential costs and disease burden averted by immunization. Results: If the entire 2015 cohort of 10-year-old girls goes without HPV immunization, approximately 125 (111–139) new cases of HPV 16, 18-related cervical cancer are expected in the future. If each health center covers a catchment area with a 5-km radius (ie, if people travel up to 5 km to obtain vaccines), then 40% of the target population could be reached to prevent 50 (44–55) cases, 178 (159–198) disability-adjusted life years, and US $202, 854 (US $140, 758–323, 693) in health care costs and lost productivity. At higher catchment area radii, additional increases in catchment area radius raise population coverage with diminishing returns. Conclusions: Much of the population in Mozambique isAbstract : Background: Research has shown that the distance to the nearest immunization location can ultimately prevent someone from getting immunized. With the introduction of human papillomavirus (HPV) vaccine throughout the world, a major question is whether the target populations can readily access immunization. Methods: In anticipation of HPV vaccine introduction in Mozambique, a country with a 2015 population of 25, 727, 911, our team developed Strategic Integrated Geo-temporal Mapping Application) to determine the potential economic impact of HPV immunization. We quantified how many people in the target population are reachable by the 1377 existing immunization locations, how many cannot access these locations, and the potential costs and disease burden averted by immunization. Results: If the entire 2015 cohort of 10-year-old girls goes without HPV immunization, approximately 125 (111–139) new cases of HPV 16, 18-related cervical cancer are expected in the future. If each health center covers a catchment area with a 5-km radius (ie, if people travel up to 5 km to obtain vaccines), then 40% of the target population could be reached to prevent 50 (44–55) cases, 178 (159–198) disability-adjusted life years, and US $202, 854 (US $140, 758–323, 693) in health care costs and lost productivity. At higher catchment area radii, additional increases in catchment area radius raise population coverage with diminishing returns. Conclusions: Much of the population in Mozambique is unable to reach any existing immunization location, thereby reducing the potential impact of HPV vaccine. The geospatial information system analysis can assist in planning vaccine introduction strategies to maximize access and help the population reap the maximum benefits from an immunization program. Abstract : Geospatial information system analysis found that much of population in Mozambique is not reached by any existing immunization location, reducing the potential for human papillomavirus vaccine to avert significant disease burden and costs. … (more)
- Is Part Of:
- Sexually transmitted diseases. Volume 44:Issue 4(2017)
- Journal:
- Sexually transmitted diseases
- Issue:
- Volume 44:Issue 4(2017)
- Issue Display:
- Volume 44, Issue 4 (2017)
- Year:
- 2017
- Volume:
- 44
- Issue:
- 4
- Issue Sort Value:
- 2017-0044-0004-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-04
- Subjects:
- Sexually transmitted diseases -- Periodicals
Sexual health -- Periodicals
616.951005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00007435-000000000-00000 ↗
http://www.stdjournal.com ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/OLQ.0000000000000574 ↗
- Languages:
- English
- ISSNs:
- 0148-5717
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8254.486500
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8239.xml